Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-042826

Director acquired 52,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Johnson Karen Marie Director 2023-12-26 Grant or award +52,000 115,185 D
Loading xslF345X05/wk-form4_1703803101.xml…